We purified and sequenced the heat-stable enterotoxin produced by Citrobacter freundii. The toxin was detected during purification by reaction with monoclonal antibody to Escherichia coli heat-stable enterotoxin. The C. freundii toxin amino acid sequence was identical to that of the 18-amino-acid heat-stable enterotoxin (STa) produced by toxigenic E. coli.
can detect both 18-and 19-amino acid E. coli STa and the core sequence corresponding to the 11-carboxy-terminal amino acids of the 18-amino-acid STa (15, 17) . The possibility that the Citrobacter toxin might be structurally related to either of these small peptide toxins led us to develop a rapid, small-scale purification scheme for the toxin and to determine the primary sequence of the purified toxin.
C. freundii AG2ST (5) was grown in Casamino acid-yeast extract medium for toxin production (3) . Briefly, 2.5 ml of an overnight starter culture was used to inoculate 250 ml of medium in each of four 1-liter Erlenmeyer flasks. The culture was grown for 20 h at 37°C with shaking, and then organisms were removed by centrifugation. Culture supernatant was filter sterilized through 0.45-,um-pore-size membranes (Durapore; Millipore Corp., Bedford, Mass.).
Toxin was purified from the culture filtrate by sequential chromatography on XAD Amberlite resin, C-18 Sep-pak cartridges followed by reverse-phase high-performance liquid chromatography (HPLC). Throughout purification, toxin was detected by rapid ELISA of chromatographic fractions as previously described (15, 18) . Monoclonal antibody 20C1 used in the ELISA was kindly provided by Harvey Brandwein, Genetic Diagnostics Corp., Great Neck, N.Y. Fractions containing toxin were identified within 2 h of each separation. HPLC separations were also monitored by A280 (first HPLC) or A214 (second and third HPLC separations).
The culture filtrate (950 ml) was applied to a 40-mlbed-volume column of XAD-2 Amberlite resin (Rohm & Haas Co., Philadelphia, Pa.) which had been equilibrated as previously described (11) . The XAD procedure removes most of the pigment, high-molecular-weight proteins, and salts. The XAD column eluates were pooled, concentrated, and then applied to two Sep-pak C-18 cartridges (Waters Associates, Inc., Milford, Mass.) equilibrated in 0.1% trifloroacetic acid (TFA). Both the Sep-pak and first HPLC separations removed most of the remaining pigments associated with the toxin. TFA buffer (10 ml, 0.1%) was applied to rinse nonbinding, pigmented material from each Sep-pak, and then 10 ml of methanol-0.1% TFA buffer was added in increasing concentration of methanol (10, 20, 30 , 40, 50, and 60%). The toxin activity was eluted in both 40 and 50% methanol. These eluates were pooled, concentrated, and applied to a reverse-phase HPLC column (C18 ,xBondapak, 0.39 cm by 30 cm; Waters) equilibrated in 0.1% TFA-10% methanol. The column was developed at 1 ml/min with 20% methanol for 10 min, followed by a 20 to 50% methanol gradient from 10 to 60 min. Fractions (1 ml each) were collected and assayed for toxin. Fractions containing immunoreactive material were pooled, concentrated, and then reapplied to the same column for an additional identical HPLC separation.
Only one peak of ST cross-reacting material was found in each HPLC separation chromatogram. The toxin eluted in approximately 2 ml with the methanol gradient used. The A214 profile obtained on the second column separation consisted of a broad UV-absorbing peak containing the ELISA-reactive material which defied further separation in a methanolic buffer system. The pooled ELISA-positive material was then applied to a column equilibrated in 24% acetonitrile in 0.1% TFA. After isocratic elution for 10 min, a gradient was developed from 24 to 32% acetonitrile in 0.1% TFA over 60 min. The final HPLC separation resolved one major protein peak eluting in a volume of approximately 1 ml showing ELISA reactivity separated from multiple smaller protein peaks. The toxin peak was pooled and used for all subsequent analysis. This final product was homogeneous by subsequent chromatographic and sequence analysis and was not pigmented. Analytical reverse-phase chromatography of the purified Citrobacter toxin or purified 18-amino-acid E. coli STa resulted in precisely the same retention times in acetonitrile gradients with both 0.1% TFA and 10 mM ammonium acetate (pH 5.8) buffers. When these pure STs were mixed together prior to chromatography, only one homogeneous absorbance peak was found. The purified toxin was stable for greater than 3 months when stored in 0.1% TFA-25% acetonitrile at 4°C. Pure Citrobacter toxin was assayed for amino acid composition by using an automated amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.), by suckling mouse bioassay (3), and by ELISA (15) as previously reported. We define one suckling mouse unit (MU) as the quantity of toxin required to elicit fluid response resulting in a gut/carcass ratio of 0.83 when injected in suckling mice (3) .
The small-scale purification procedure rapidly yields sufficient quantities of toxin for analytical studies (Table 1) . Approximately 440 ,ug of ST as measured by ELISA was purified from 950 ml of culture. The culture supernatant contained 530 mg of total protein as determined with BioRad protein reagent assay (Bio-Rad Laboratories, Richmond, Calif.). To monitor modification in the ST during purification, we compared the immunoreactivity of crude and purified toxin with its bioactivity in the suckling mouse assay. Recoveries of toxin biological activity (MU) and immunoreactivity (ELISA) for the purification process starting from culture supernatant were similar (19 versus 27%, respectively). The largest losses during purification were incurred at the first filtration step, where 30 to 40% of the toxin detected by both ELISA and suckling mouse assay was lost. Citrobacter toxin may either form aggregates with other proteins or pigments or remain cell associated when this strain is grown under the described conditions. Only modest losses occurred during the subsequent XAD chromatography and HPLC steps. Losses incurred at the Seppak step probably reflect overloading phenomenon, since this loss is circumvented by using additional Sep-pak cartridges (data not shown). The ELISA measured an apparent concentration of 1.6 p.g/ml in culture supernatant. If this toxin concentration is assumed to be correct, the specific biological activity of the toxin in culture supernatant is 12.4 ng/MU. This specific activity is similar to that for pure E. coli STa. The apparent specific biological activity of the purified toxin was somewhat less than that measured in culture supernatant (17 ng/MU). The apparent decrease in specific biological activity of the toxin during purification might reflect loss of toxicity. However, structural and conformational changes of the toxin that might not impair its biological activity might modify the binding of toxin to antibody, thereby changing the apparent concentration measured in the ELISA. Thus, quantitation by ELISA is not an absolute measure of the number of toxin molecules, and specific activities must be considered estimates at best. However, when the purified toxin was titrated in the competitive ELISA for E. coli STa, the resultant competition curve was parallel to that for pure E. coli STa, demonstrating essentially complete cross-reactivity and thus conservation of the antibody-binding site between the two toxins (Fig. 1) .
Purified Citrobacter toxin was reduced and carboxymethylated prior to sequence analysis to ensure complete recovery at each derivatization cycle (16 
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ND (6) a Number of residues found by amino acid analysis (number of sites with amino acid, as predicted from sequence). ND, Not detected; insufficient quantity for peak evaluation.
b Asparagine was identified by sequence analysis.
used primarily as a guide to determine the appropriate quantity for sequence analysis. Significant concentrations of contaminating amino acids were consistently found in the carboxymethylated toxin (especially serine, valine, and lysine). These amino acids were not detected upon subsequent sequence analysis and probably represent amino acids that copurified with the toxin or were introduced either during or after purification. We also have observed a similar phenomenon with low-level hydrolysis (approximately nanomole quantities) of E. coli STa. Nevertheless, the apparent yield of purified toxin, on the basis of amino acid assignments from sequence data and amino acid analysis of the reduced, carboxymethylated toxin, is similar to the ELISA estimate (530 jig by amino acid analysis of carboxymethylated toxin; 440 pug by ELISA). Approximately 2.5 nmol of purified, carboxymethylated toxin was sequenced with an automated gas phase sequencer (Applied Biosystems) as previously described (16) . Sequence analysis was performed by Steve Gathy, University of Kentucky Protein Sequencing Facility, Lexington, Ky. Phenylthiohydantoin (PTH)-amino acids were identified and quantitated by HPLC at each of 20 cycles. No contaminating peptides were found from HPLC analysis of the PTH-amino acids obtained at each cycle. Several amino acids found by amino acid analysis (Table 2) were not found by sequence analysis, suggesting that they represent contamination that washed out or were not immobilized prior to the first PTH derivitization cycle. The Cys residues were identified as PTH CM-Cys derivatives. No new amino acids were detected after cycle 18. The ST produced by C. freundii is an octadecapeptide consisting of the identical amino acid sequence of the 18-amino-acid STa (ST Ta) produced by E. coli: Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-ProAla-Cys-Ala-Gly-Cys-Tyr (COOH terminus).
The role of the Citrobacter toxin in inducing diarrhea in patients is not known, but the relative biological potency of Citrobacter toxin is very similar to that of pure E. coli STa. Furthermore, the strain chosen for toxin purification produced more toxin in vitro than did 75% of the E. coli toxigenic strains tested in the ELISA, even though the Citrobacter growth conditions were optimized for E. coli growth and toxin production (M. R. Thompson, unpublished observations) . The ELISA for ST should be a useful tool to aid in the identification of both enterotoxigenic E. coli and C. freundii isolates from diarrheal stools.
The production of an ST by a Citrobacter sp. which is identical to a toxin normally associated with entertoxigenic E. coli raises the possibility that the organisms may trade plasmids. We have previously reported that toxigenic C. freundii was isolated from a patient also harboring an STproducing E. coli strain (5) . However, at this time we have no evidence whether the structural gene coding for Citrobacter toxin is plasmid or chromosomal.
A problem in nomenclature has arisen. The toxin produced by C. freundii is in all respects identical to the 18-amino-acid STa (ST I) already identified in enterotoxigenic E. coli. This toxin also has been called ST 
